CMVLF (Cellectis) SpecialCharges


CMVLF Cellectis SA CMVLF
60 GF Score
Price $3.47
GF Value $3.74
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cellectis SpecialCharges?

Special Charges only applies to banks.

CMVLF
60GF Score
Cellectis SA CMVLF
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cellectis (CMVLF) Overvalued in 2026?

Based on GuruFocus' analysis, Cellectis stock appears to be undervalued. The current stock price of $3.47 is trading 7.2% below its estimated GF Value™ of $3.74. GuruFocus considers Cellectis to be Fairly Valued.

Key valuation signals for CMVLF:

  • SpecialCharges:
  • GF Value™: $3.74 vs. price of $3.47 (7.2% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the CMVLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cellectis Business Description

Address 8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
60GF Score

Get the complete analysis for CMVLF

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.47
Price
$3.74
GF Value